Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01147601 · ClinicalTrials.gov registry record · Early Phase 1
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT01147601: Clinical Trial Early Phase 1 study, sponsored by Oregon Health and Science University.
NCT01147601 is a Early Phase 1 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 6 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01147601, a Early Phase 1 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas. This study would examine whether topical timolol could be a potential therapy.
Primary Outcome
This will be generated by asking each of the assessors to score the improvement using a visual analog scale (VAS) assessing the decrease in size of hemangioma by comparing photographs at different times of treatment. The assessors will score this improvement into one of the following categories: 0-24%, 25-49%, 50-74%, \>75%.
Interventions
- DRUG topical 0.5% Timolol
- DRUG Control (placebo) group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-08 |
| Phase | Early Phase 1 |
Why NCT01147601 stopped before completion
NCT01147601 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which topical 0.5% Timolol is the first listed.
NCT01147601 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01147601 about?
NCT01147601 is a clinical study titled "Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas". The purpose of this study is to learn about a new potential use for topical timolol 0.5% aqueous solution that may help treat small uncomplicated infantile hemangiomas. This study would examine whether topical timolol could be a potential therapy.
What is the current status of trial NCT01147601?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2010-03. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01147601?
The interventions under investigation include: topical 0.5% Timolol (DRUG), Control (placebo) group (DRUG).
Who is sponsoring clinical trial NCT01147601?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01147601's enrollment target sits among peer trials
6 1845th of 2000 higher than 114 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia